Clinical Trials - TNYA

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06228924Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCRECRUITINGPHASE12024-03-262029-10-012026-05-01
NCT05836259Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCMRECRUITINGPHASE1, PHASE22023-08-102032-082027-08